+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Immunovaccine Inc (IMV) - Financial and Strategic SWOT Analysis Review

  • ID: 4281638
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
  • IMV Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Immunovaccine Inc (IMV), formerly Rhino Resources Inc is a clinical-stage immuno-oncology company that develops cancer immunotherapies and infectious disease vaccines. The company develops its products based on DepoVax platform, a vaccine adjuvant and delivery platform technology. Its immuno oncology pipeline products are intended for the treatment of ovarian, diffuse large B cell lymphoma (DLBCL) tumors and human papillomavirus (HPV) cervical cancer. IMV’s infectious disease product candidates are intended for the treatment of respiratory syncytial virus, malaria and others. The company partners with various universities, research institutes and other vaccine development companies to develop its product candidates for applications in cancer and infectious diseases. IMV is headquartered in Halifax, Nova Scotia, Canada.

Immunovaccine Inc Key Recent Developments

Jan 31, 2018: Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology and Enhanced Efficacy in Slowing Tumor Progression
Jan 18, 2018: Immunovaccine Appoints Joseph Sullivan as Senior Vice President of Business Development
Nov 09, 2017: Immunovaccine Announces Third Quarter 2017 Financial Results
Oct 17, 2017: Immunovaccine Receives an Extension to the Maturity Date of its $5M Loan Until 2020
Aug 08, 2017: Immunovaccine Announces Financial Results for Quarter Ended June 30, 2017

This comprehensive SWOT profile of Immunovaccine Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Immunovaccine Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Immunovaccine Inc - Key Information
  • Immunovaccine Inc - Overview
  • Immunovaccine Inc - Key Employees
  • Immunovaccine Inc - Key Employee Biographies
  • Immunovaccine Inc - Key Operational Heads
  • Immunovaccine Inc - Major Products and Services
  • Immunovaccine Inc - History
  • Immunovaccine Inc - Company Statement
  • Immunovaccine Inc - Locations And Subsidiaries
  • Immunovaccine Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Immunovaccine Inc - Business Description
  • Immunovaccine Inc - Corporate Strategy
  • Immunovaccine Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Immunovaccine Inc - Strengths
  • Immunovaccine Inc - Weaknesses
  • Immunovaccine Inc - Opportunities
  • Immunovaccine Inc - Threats
  • Immunovaccine Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Immunovaccine Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Immunovaccine Inc, Key Information
  • Immunovaccine Inc, Key Ratios
  • Immunovaccine Inc, Share Data
  • Immunovaccine Inc, Major Products and Services
  • Immunovaccine Inc, History
  • Immunovaccine Inc, Key Employees
  • Immunovaccine Inc, Key Employee Biographies
  • Immunovaccine Inc, Key Operational Heads
  • Immunovaccine Inc, Other Locations
  • Immunovaccine Inc, Subsidiaries
  • Immunovaccine Inc, Key Manufacturing facilities
  • Immunovaccine Inc, Key Competitors
  • Immunovaccine Inc, SWOT Analysis
  • Immunovaccine Inc, Ratios based on current share price
  • Immunovaccine Inc, Annual Ratios
  • Immunovaccine Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Immunovaccine Inc, Performance Chart
  • Immunovaccine Inc, Ratio Charts
Note: Product cover images may vary from those shown